CAD 0.06
(-7.69%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 40.44 Million CAD | 51.22% |
2022 | 26.74 Million CAD | 20.46% |
2021 | 22.2 Million CAD | 29.14% |
2020 | 17.19 Million CAD | 204.37% |
2019 | 5.64 Million CAD | -49.12% |
2018 | 11.1 Million CAD | 70384.41% |
2017 | 15.75 Thousand CAD | -45.21% |
2016 | 28.74 Thousand CAD | -70.11% |
2015 | 96.16 Thousand CAD | -33.69% |
2014 | 145.03 Thousand CAD | -3.89% |
2013 | 150.91 Thousand CAD | 25.67% |
2012 | 120.08 Thousand CAD | -2.84% |
2011 | 123.59 Thousand CAD | -8.19% |
2010 | 134.61 Thousand CAD | -29.01% |
2009 | 189.61 Thousand CAD | -69.32% |
2008 | 618.01 Thousand CAD | -42.24% |
2007 | 1.06 Million CAD | 64.24% |
2006 | 651.47 Thousand CAD | 62.1% |
2005 | 401.89 Thousand CAD | 140.0% |
2004 | 167.45 Thousand CAD | 112.67% |
2003 | 78.73 Thousand CAD | 18.67% |
2002 | 66.35 Thousand CAD | 25.07% |
2001 | 53.04 Thousand CAD | -20.44% |
2000 | 66.67 Thousand CAD | -22.2% |
1999 | 85.7 Thousand CAD | 27.95% |
1998 | 66.97 Thousand CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 7.22 Million CAD | -34.34% |
2024 Q2 | 6.56 Million CAD | 8.58% |
2023 Q2 | 7.97 Million CAD | -14.06% |
2023 Q4 | 11 Million CAD | 21.97% |
2023 Q3 | 9.02 Million CAD | 13.18% |
2023 FY | 34.76 Million CAD | 29.97% |
2023 Q1 | 9.27 Million CAD | 13.77% |
2022 Q1 | 6.48 Million CAD | 0.75% |
2022 Q3 | 5.72 Million CAD | -13.23% |
2022 Q4 | 8.15 Million CAD | 42.43% |
2022 FY | 26.74 Million CAD | 20.46% |
2022 Q2 | 6.59 Million CAD | 1.74% |
2021 Q1 | 4.78 Million CAD | -1.22% |
2021 Q4 | 6.43 Million CAD | 29.1% |
2021 FY | 22.2 Million CAD | 29.14% |
2021 Q3 | 4.98 Million CAD | -16.84% |
2021 Q2 | 5.99 Million CAD | 25.28% |
2020 Q3 | 3.77 Million CAD | -6.04% |
2020 FY | 17.19 Million CAD | 204.37% |
2020 Q4 | 4.84 Million CAD | 28.24% |
2020 Q1 | 4.55 Million CAD | 136.21% |
2020 Q2 | 4.02 Million CAD | -11.63% |
2019 Q3 | 4.98 Million CAD | -26.76% |
2019 Q1 | 6.38 Million CAD | 0.0% |
2019 Q2 | 6.81 Million CAD | 6.69% |
2019 FY | 5.64 Million CAD | -49.12% |
2019 Q4 | -12.56 Million CAD | -351.85% |
2018 Q1 | 14.97 Thousand CAD | -69.81% |
2018 FY | 11.1 Million CAD | 70384.41% |
2018 Q2 | 122.3 Thousand CAD | 716.94% |
2018 Q3 | 166.01 Thousand CAD | 35.74% |
2017 Q1 | 2216.00 CAD | -41.99% |
2017 FY | 15.75 Thousand CAD | -45.21% |
2017 Q4 | 49.59 Thousand CAD | 2444.43% |
2017 Q3 | 1949.00 CAD | -74.78% |
2017 Q2 | 7727.00 CAD | 248.69% |
2016 Q3 | 1988.00 CAD | -74.04% |
2016 Q4 | 3820.00 CAD | 92.15% |
2016 FY | 28.74 Thousand CAD | -70.11% |
2016 Q1 | 2528.00 CAD | -70.27% |
2016 Q2 | 7658.00 CAD | 202.93% |
2015 Q1 | 21.57 Thousand CAD | -35.39% |
2015 FY | 96.16 Thousand CAD | -33.69% |
2015 Q3 | 10.06 Thousand CAD | -26.22% |
2015 Q4 | 8502.00 CAD | -15.5% |
2015 Q2 | 13.63 Thousand CAD | -36.78% |
2014 Q2 | 20.72 Thousand CAD | -65.69% |
2014 Q3 | 25.07 Thousand CAD | 21.02% |
2014 Q1 | 60.38 Thousand CAD | 75.08% |
2014 Q4 | 33.38 Thousand CAD | 33.14% |
2014 FY | 145.03 Thousand CAD | -3.89% |
2013 Q4 | 34.49 Thousand CAD | 17.16% |
2013 FY | 150.91 Thousand CAD | 25.67% |
2013 Q2 | 23.83 Thousand CAD | -36.23% |
2013 Q3 | 29.43 Thousand CAD | 23.51% |
2013 Q1 | 37.38 Thousand CAD | -34.34% |
2012 Q3 | 32.76 Thousand CAD | 34.8% |
2012 Q1 | 38.18 Thousand CAD | 16.07% |
2012 FY | 120.08 Thousand CAD | -2.84% |
2012 Q4 | 56.93 Thousand CAD | 73.79% |
2012 Q2 | 24.3 Thousand CAD | -36.36% |
2011 FY | 123.59 Thousand CAD | -8.19% |
2011 Q4 | 32.89 Thousand CAD | 33.19% |
2011 Q3 | 24.7 Thousand CAD | -10.78% |
2011 Q2 | 27.68 Thousand CAD | -16.24% |
2011 Q1 | 33.05 Thousand CAD | -4.53% |
2010 Q4 | 34.61 Thousand CAD | 22.58% |
2010 Q3 | 28.24 Thousand CAD | -3.45% |
2010 FY | 134.61 Thousand CAD | -29.01% |
2010 Q2 | 29.24 Thousand CAD | -19.01% |
2010 Q1 | 36.11 Thousand CAD | -10.66% |
2009 Q3 | 28.82 Thousand CAD | -24.48% |
2009 FY | 189.61 Thousand CAD | -69.32% |
2009 Q4 | 40.42 Thousand CAD | 40.23% |
2009 Q2 | 38.17 Thousand CAD | -42.75% |
2009 Q1 | 66.67 Thousand CAD | -11.51% |
2008 FY | 618.01 Thousand CAD | -42.24% |
2008 Q1 | 172.72 Thousand CAD | 17.72% |
2008 Q2 | 200.03 Thousand CAD | 15.81% |
2008 Q3 | 9415.00 CAD | -95.29% |
2008 Q4 | 75.35 Thousand CAD | 700.36% |
2007 Q3 | 98.53 Thousand CAD | 2.28% |
2007 Q4 | 146.72 Thousand CAD | 48.91% |
2007 Q2 | 96.34 Thousand CAD | -54.24% |
2007 Q1 | 210.55 Thousand CAD | -69.72% |
2007 FY | 1.06 Million CAD | 64.24% |
2006 Q2 | 12.3 Thousand CAD | -94.45% |
2006 Q3 | 67.72 Thousand CAD | 450.22% |
2006 Q1 | 221.71 Thousand CAD | -38.42% |
2006 FY | 651.47 Thousand CAD | 62.1% |
2006 Q4 | 695.35 Thousand CAD | 926.72% |
2005 Q4 | 360.04 Thousand CAD | 527.15% |
2005 Q1 | 181.53 Thousand CAD | 18.98% |
2005 Q3 | 57.4 Thousand CAD | 87.77% |
2005 Q2 | 30.57 Thousand CAD | -83.16% |
2005 FY | 401.89 Thousand CAD | 140.0% |
2004 Q2 | 75.13 Thousand CAD | 120.23% |
2004 Q4 | 152.57 Thousand CAD | 310.09% |
2004 Q3 | 37.2 Thousand CAD | -50.48% |
2004 FY | 167.45 Thousand CAD | 112.67% |
2004 Q1 | 34.11 Thousand CAD | 29.87% |
2003 Q3 | 19.65 Thousand CAD | 4.88% |
2003 FY | 78.73 Thousand CAD | 18.67% |
2003 Q4 | 26.26 Thousand CAD | 33.62% |
2003 Q1 | 21.02 Thousand CAD | -22.74% |
2003 Q2 | 18.74 Thousand CAD | -10.83% |
2002 Q4 | 27.2 Thousand CAD | 131.19% |
2002 Q3 | 11.76 Thousand CAD | -4.42% |
2002 Q1 | 19.8 Thousand CAD | -7.28% |
2002 FY | 66.35 Thousand CAD | 25.07% |
2002 Q2 | 12.31 Thousand CAD | -37.83% |
2001 Q4 | 21.35 Thousand CAD | 27.1% |
2001 Q3 | 16.8 Thousand CAD | 139.83% |
2001 Q2 | 7007.00 CAD | 8.13% |
2001 Q1 | 6480.00 CAD | 0.0% |
2001 FY | 53.04 Thousand CAD | -20.44% |
2000 FY | 66.67 Thousand CAD | -22.2% |
2000 Q2 | 11.14 Thousand CAD | 35.39% |
2000 Q3 | 13.39 Thousand CAD | 20.19% |
2000 Q1 | 8229.00 CAD | 0.0% |
1999 FY | 85.7 Thousand CAD | 27.95% |
1999 Q3 | 15.79 Thousand CAD | 0.0% |
1998 FY | 66.97 Thousand CAD | 0.0% |
1998 Q3 | 17.49 Thousand CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 2.96 Million CAD | -1264.633% |
CanadaBis Capital Inc. | 7.1 Million CAD | -469.131% |
Delivra Health Brands Inc. | 7.1 Million CAD | -468.955% |
Entourage Health Corp. | 3.7 Million CAD | -990.893% |
Lifeist Wellness Inc. | 17.59 Million CAD | -129.887% |
Cannara Biotech Inc. | 15.34 Million CAD | -163.62% |
Medicure Inc. | 13.98 Million CAD | -189.134% |
PharmaCielo Ltd. | 8.33 Million CAD | -385.436% |
Rubicon Organics Inc. | 14.22 Million CAD | -184.353% |
BioSyent Inc. | 17.6 Million CAD | -129.704% |
Voyageur Pharmaceuticals Ltd. | 1.22 Million CAD | -3212.743% |